Crescent Biopharma, Inc. (CBIO)
Crescent Biopharma Market Cap: 164.63M for Dec. 19, 2025
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| XOMA Royalty Corp. | 314.41M |
| Viridian Therapeutics, Inc. | 3.047B |
| DiaMedica Therapeutics, Inc. | 441.62M |
| Denali Therapeutics, Inc. | 2.631B |
| Praxis Precision Medicines, Inc. | 6.825B |
Market Cap Related Metrics
| Price to Book Value | 1.462 |
| Price | 11.85 |
| Earnings Yield | -185.4% |